Aehr Test Systems (NASDAQ:AEHR – Get Free Report) EVP Alberto Salamone sold 9,672 shares of the company’s stock in a transaction dated Thursday, August 13th. The shares were sold at an average price of $127.72, for a total transaction of $1,235,307.84. Following the sale, the executive vice president directly owned 41,962 shares of the company’s stock, valued at approximately $5,359,386.64. This represents a 18.73% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.
Aehr Test Systems Trading Up 8.7%
AEHR stock opened at $134.06 on Friday. The firm has a 50-day moving average of $92.83 and a two-hundred day moving average of $71.45. Aehr Test Systems has a 12 month low of $16.38 and a 12 month high of $147.40. The company has a market cap of $4.37 billion, a price-to-earnings ratio of -558.56 and a beta of 3.10.
Aehr Test Systems News Summary
Here are the key news stories impacting Aehr Test Systems this week:
- Positive Sentiment: Jefferies initiated coverage with a bullish view, helping drive renewed investor interest. The analyst reportedly described the price target as conservative and identified additional potential catalysts that were not included in the model. Jefferies Initiates Coverage on Aehr Test Systems
- Positive Sentiment: Aehr received a $22 million follow-on order from its lead customer for wafer-level burn-in systems used with advanced AI training and inference processors. The repeat business supports demand for the company’s FOX systems and strengthens its position in AI and high-performance computing. Aehr Receives $22 Million Follow-on Order
- Positive Sentiment: Recent company updates pointed to record quarterly bookings of $60.7 million, a backlog of approximately $100.6 million and fiscal 2027 revenue guidance of $130 million to $150 million. These figures provide revenue visibility and support the investment case tied to rising AI-chip testing demand. Aehr AI Order and WLBI Opportunity
- Neutral Sentiment: CEO Gayn Erickson and CFO Chris Siu will meet investors at the Needham Virtual Semiconductor and SemiCap 1×1 Conference on August 19. The event could provide further commentary on backlog conversion and fiscal 2027 execution, but no new financial information was announced. Aehr to Participate in Needham Conference
- Negative Sentiment: Several insiders sold shares after AEHR’s sharp rally. The transactions included the CEO’s sale of 40,000 shares for about $5.2 million, the COO’s sale of 15,000 shares for roughly $2.0 million, and additional director and executive sales. Although insiders retained sizable positions—and the CEO sale came from a trust—such activity may signal profit-taking and add selling pressure. Aehr CEO Share Sale
- Negative Sentiment: One analyst began coverage on a bearish note, highlighting the risk that expectations have become difficult to meet after the stock’s extraordinary advance. AEHR’s elevated valuation and dependence on continued AI order growth leave it vulnerable if bookings, backlog conversion or execution disappoints. Bearish Analyst Initiation
Analyst Ratings Changes
Read Our Latest Stock Analysis on AEHR
Institutional Trading of Aehr Test Systems
A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Jupiter Topco LLC purchased a new stake in shares of Aehr Test Systems during the 2nd quarter valued at approximately $1,172,000. AWM Investment Company Inc. acquired a new position in Aehr Test Systems in the second quarter valued at approximately $36,004,000. Legal & General Group Plc purchased a new position in Aehr Test Systems in the second quarter worth approximately $2,288,000. The Manufacturers Life Insurance Company purchased a new position in Aehr Test Systems in the second quarter worth approximately $1,007,000. Finally, Algert Global LLC purchased a new position in Aehr Test Systems in the second quarter worth approximately $7,903,000. Institutional investors and hedge funds own 69.69% of the company’s stock.
Aehr Test Systems Company Profile
Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.
The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.
Featured Articles
- Five stocks we like better than Aehr Test Systems
- Sony and TSMC’s $4.7 Billion Venture Is About More Than Camera Sensors
- Quantum Leaps: Debt-Free as AI Storage Demand Accelerates
- NVIDIA’s $500 Billion GPU Financing Deal Fuels Path Toward $270
- Sandisk’s Margins Look Like Software. Can They Last?
Receive News & Ratings for Aehr Test Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aehr Test Systems and related companies with MarketBeat.com's FREE daily email newsletter.
